Clinical experience

Today, several thousand eyes have been cross-linked world wide and follow-ups of more than 10 years are available.

Clinical studies in larger cohorts of patients have shown a significant increase in best corrected visual acuity (BCVA) in more than 85% of the treated eyes.

Six months after corneal cross-linking, the refractive cylinder is reduced in over 80% of the eyes. Consequently corneal cross-linking induces a restoring biomechanical force upon the deformed corneal shape.

tl_files/irocmedical/Clinical experience 1.png

Gain of lines after corneal cross-linking found in more than 50% of the eyes

 

The steepest K-value is usually decreased by 1 Diopter and the percentage of eyes that had a clinical relevant reduction exceeds 86%.

An increase of one to two lines was observed between 9 to 30 months after the treatment. Increases of up to three to four lines were observed from 30 to 60 months.

tl_files/irocmedical/Clinical experience 2.png

Example: Topography of a keratoconus eye before (left) and 4 months after (right) corneal cross-linking. A significantly smoother corneal surface was observed.

 

A large number of studies are currently under way or have alredy been performed using the IROC UV-XTM device.

Selected publications on corneal cross linking 

  • Spoerl E, Huhle M, Kasper M, Seiler T: Artificial stiffening of the cornea by induction of intrastromal cross-links. Der Ophthalmologe 94 (1997), p. 902-906
  • Spoerl E, Huhle M, Seiler T: Induction of cross-links in corneal tissue. Exp. Eye Res. 66 (1998), p. 97-103
  • Spoerl E, Seiler T: Techniques for stiffening the cornea. J. Refract. Surg. 15 (1999), p. 711-713
  • Kanellopoulos, AJ; Binder, PS. Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty. Cornea, 2007 Aug, 26(7):891-5
  • Wollensak, G. Crosslinking treatment of progressive keratoconus: new hope. Current opinion in ophthalmology, 2006 Aug, 17(4):356-60
  • Kohlhaas, M; Spoerl, E; Schilde, T; Unger, G; Wittig, C; Pillunat, LE. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. Journal of cataract and refractive surgery, 2006 Feb, 32(2):279-83
  • Kohlhaas, M; Spoerl, E; Speck, A; Schilde, T; Sandner, D; Pillunat, LE. A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking. Klinische Monatsblatter fur Augenheilkunde, 2005 May, 222(5):430-6
  • Wollensak, G; Spörl, E; Seiler, T. Treatment of keratoconus by collagen cross linking. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003 Jan, 100(1):44-9

Newsflash

7th International Congress of Corneal Cross-Linking (CXL)

Corneal cross-linking has evolved from an exotic concept to a well-established procedure, used all over the world. The great interest in basic research and clinical experience is attracting an increasing number of ophthalmologists. This meeting disseminates the latest knowledge on corneal cross-linking.

Read more …

NOW AVAILABLE: UV-X 2000

The new UV-X beam optimized illumination system is the first device that features an optimized beam profile to maximize the cross-linking volume.

Read more …

Quality Management

IROC is certified according to EN ISO 13485:2003 & MDD 93/42/EEC Annex II

Read more …